NCT02908191View on ClinicalTrials.gov

A Study in Healthy Volunteers and Patients With Chronic Hepatitis B

PHASE1CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

March 31, 2018

Study Completion Date

June 12, 2018

Conditions
Chronic Hepatitis B
Interventions
DRUG

ABI-H0731

DRUG

Placebo for ABI-H0731

DRUG

Entecavir

Used to treat adults with chronic hepatitis B virus

DRUG

Tenofovir disoproxil fumarate

Used to treat adults with chronic hepatitis B virus

DRUG

Pegasys

Used to treat adults with chronic hepatitis B virus who show signs of liver damage

DRUG

Nucleos(t)ide

Used to treat adults with chronic hepatitis B virus

Trial Locations (2)

Unknown

Auckland

Hamilton

Sponsors
All Listed Sponsors
lead

Assembly Biosciences

INDUSTRY

NCT02908191 - A Study in Healthy Volunteers and Patients With Chronic Hepatitis B | Biotech Hunter | Biotech Hunter